Session Information
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
MA02 - RET and Novel Combinations of Osimertinib
- 09:30 - 10:30
- 9/08/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Novel Therapeutics and Targeted Therapies
-
+
MA02.07 - T-DM1 and Osimertinib (TRAEMOS) To Target HER2 Bypass Track Resistance in EGFRm+ NSCLC: Interim Analysis of a Phase II Trial
10:10 - 10:15 | Presenter: Merel Jebbink
- Abstract
Loading...
-
+
P63 - Small Cell Lung Cancer/ NET - Clinical Studies
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Small Cell Lung Cancer/ NET
-
+
P63.12 - Radiotherapy for Small Cell Lung Cancer in Current Clinical Practice Guidelines
00:00 - 00:00 | Presenter: Haiyan Zeng
- Abstract
Loading...
-
+
ES06 - Immuno-Biology and Novel Immunotherapeutics in Lung Cancer*
- 09:45 - 10:20
- 9/10/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Education Session
- Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
*Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.- Moderators:Jordi Remon, Lizza Hendriks
-
+
ES06.01 - Task Force in Methodology: Developing New Trials with Immunotherapeutic Agents
09:45 - 09:47 | Presenter: Rosalyn Juergens
- Abstract
No abstract available for this presentation
-
+
ES06.02 - Bi-Specific Agents
09:47 - 09:49 | Presenter: Taofeek Owonikoko
- Abstract
No abstract available for this presentation
-
+
ES06.03 - "Not Just Another irAE" - Identification and Management of Immunotoxicities of Bispecifics and CAR-T
09:49 - 09:51 | Presenter: Melissa Johnson
- Abstract
No abstract available for this presentation
-
+
ES06.04 - Intra-tumoral Immunotherapy
09:51 - 09:53 | Presenter: Stephane Champiat
- Abstract
No abstract available for this presentation
-
+
ES06.05 - Approach to Chemotherapy for Oncogene-driven Cancers: Known Barriers and Future Promise
09:53 - 09:55 | Presenter: Noemi Reguart
- Abstract
No abstract available for this presentation
-
+
ES06.06 - Live Discussion with Speakers
09:55 - 10:20
- Abstract
No abstract available for this presentation
